150 related articles for article (PubMed ID: 38419219)
1. Retrospective analysis of the clinical significance of Ro52/TRIM21 antibody and specific antinuclear antibody patterns by indirect immunofluorescence.
Liu K; Liao Y; Li P; Shi J
J Pak Med Assoc; 2024 Feb; 74(2):236-242. PubMed ID: 38419219
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
Front Immunol; 2019; 10():444. PubMed ID: 30915082
[TBL] [Abstract][Full Text] [Related]
3. Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis.
Chan EKL
Clin Rev Allergy Immunol; 2022 Oct; 63(2):178-193. PubMed ID: 35040083
[TBL] [Abstract][Full Text] [Related]
4. A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.
Lee AYS
Rheumatol Int; 2017 Aug; 37(8):1323-1333. PubMed ID: 28417151
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
Front Immunol; 2018; 9():1200. PubMed ID: 29922285
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Different Profiles of anti-Ro Antibodies in Connective Tissue Diseases.
Yang HT; Hong XP; Guo JW; Zhong XL; Liao R; Liu CL; Liu LX; Li K; Chen YL; Liu DZ
J Immunol Res; 2023; 2023():9195157. PubMed ID: 36741231
[TBL] [Abstract][Full Text] [Related]
7. Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain.
Menor Almagro R; Jurado Roger A; Rodríguez Gutiérrez FJ; Solís Díaz R; Cardiel MH; Salaberri Maestrojuan JJ
Reumatol Clin; 2016; 12(5):256-62. PubMed ID: 26725021
[TBL] [Abstract][Full Text] [Related]
8. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
9. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome.
Ricchiuti V; Isenberg D; Muller S
J Autoimmun; 1994 Oct; 7(5):611-21. PubMed ID: 7530962
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.
Frodlund M; Wetterö J; Dahle C; Dahlström Ö; Skogh T; Rönnelid J; Sjöwall C
Clin Exp Immunol; 2020 Mar; 199(3):245-254. PubMed ID: 31778219
[TBL] [Abstract][Full Text] [Related]
11. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.
Murng SHK; Thomas M
J Clin Pathol; 2018 Jan; 71(1):12-19. PubMed ID: 28663326
[TBL] [Abstract][Full Text] [Related]
12. Importance of detection of SS-A/Ro autoantibody in screening immunofluorescence tests for autoantibodies to nuclear antigens.
Bylund DJ; Nakamura RM
J Clin Lab Anal; 1991; 5(3):212-8. PubMed ID: 2061745
[TBL] [Abstract][Full Text] [Related]
13. Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
Zampeli E; Mavrommati M; Moutsopoulos HM; Skopouli FN
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):134-141. PubMed ID: 32083547
[TBL] [Abstract][Full Text] [Related]
14. Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome.
Buvry C; Cassagnes L; Tekath M; Artigues M; Pereira B; Rieu V; Le Guenno G; Tournadre A; Ruivard M; Grobost V
Respir Med; 2020 Mar; 163():105895. PubMed ID: 32056839
[TBL] [Abstract][Full Text] [Related]
15. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
[TBL] [Abstract][Full Text] [Related]
16. Routine immunofluorescence detection of Ro/SS-A autoantibody using HEp-2 cells transfected with human 60 kDa Ro/SS-A.
Pollock W; Toh BH
J Clin Pathol; 1999 Sep; 52(9):684-7. PubMed ID: 10655991
[TBL] [Abstract][Full Text] [Related]
17. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management.
Decker P; Moulinet T; Pontille F; Cravat M; De Carvalho Bittencourt M; Jaussaud R
Autoimmun Rev; 2022 Mar; 21(3):103013. PubMed ID: 34896652
[TBL] [Abstract][Full Text] [Related]
18. Rare immunofluorescence patterns of autoantibodies on HEp-2 cells defined by ICAP identify different autoimmune diseases in the absence of associated specificities: a Spanish multicentre study.
Irure-Ventura J; Rodríguez C; Vergara-Prieto E; Vargas ML; Quirant B; Jurado A; Fernández-Pereira L; Martínez-Cáceres E; San José M; López-Hoyos M;
Rheumatology (Oxford); 2021 Aug; 60(8):3904-3912. PubMed ID: 33437990
[TBL] [Abstract][Full Text] [Related]
19. Speckled antinuclear antibodies in keratinocytes--what does it mean?
Bukilica MN; Andrejevic SB; Bonaci-Nikolic BM; Nikolic MM
Clin Exp Rheumatol; 2002; 20(4):499-504. PubMed ID: 12175105
[TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations in anti-Ro52/SS-A antibody-seropositive patients with Sjögren's syndrome.
Nakamura H; Morimoto S; Shimizu T; Takatani A; Nishihata SY; Kawakami A
Immunol Med; 2021 Dec; 44(4):252-262. PubMed ID: 33989125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
